| RS121918312 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS121918313 |
LRP6
|
Health Risk |
Pathogenic |
Coronary artery disease, autosomal dominant 2 |
| RS121918314 |
BCL10
|
Health Risk |
Pathogenic |
MALE GERM CELL TUMOR, SOMATIC |
| RS121918315 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS121918316 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS121918317 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS121918318 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS121918319 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS121918320 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS121918321 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS121918322 |
FGF9
|
Health Risk |
Pathogenic |
Multiple synostoses syndrome 3, Multiple synostoses syndrome 3 |
| RS121918323 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, Variegate porphyria |
| RS121918324 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, childhood-onset |
| RS121918325 |
PPOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Variegate porphyria, childhood-onset |
| RS121918326 |
PPOX
|
Health Risk |
Pathogenic |
Variegate porphyria, Variegate porphyria |
| RS121918327 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS121918328 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS121918329 |
HIBCH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-hydroxyisobutyryl-CoA hydrolase deficiency, Inborn genetic diseases |
| RS121918330 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS121918331 |
SLC25A38
|
Health Risk |
Conflicting classifications of pathogenicity |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS121918332 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS121918334 |
SLC25A22
|
Health Risk |
Pathogenic/Likely pathogenic |
Early myoclonic encephalopathy, Developmental and epileptic encephalopathy |
| RS121918335 |
SLC25A22
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 3 |
| RS121918336 |
PIKFYVE
|
Health Risk |
Pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS121918337 |
PIKFYVE
|
Health Risk |
Pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS121918338 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS121918339 |
SLC17A8
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 25, Autosomal dominant nonsyndromic hearing loss 25 |
| RS121918340 |
NSMF
|
Health Risk |
risk factor |
Hypogonadotropic hypogonadism 9 with or without anosmia, Hypogonadotropic hypogonadism 9 with or without anosmia |
| RS121918341 |
SEMA3E
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS121918342 |
AKR1D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital bile acid synthesis defect 2, Congenital bile acid synthesis defect 2 |
| RS121918343 |
AKR1D1
|
Health Risk |
Pathogenic |
Congenital bile acid synthesis defect 2, Congenital bile acid synthesis defect 2 |
| RS121918344 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS121918347 |
SMO
|
Health Risk |
Pathogenic |
Basal cell carcinoma, somatic |
| RS121918348 |
SMO
|
Health Risk |
Pathogenic |
Basal cell carcinoma, somatic |
| RS121918349 |
WNT10B
|
Health Risk |
Pathogenic |
Split hand-foot malformation 6, Split hand-foot malformation 6 |
| RS121918350 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, JAG1-related disorder |
| RS121918351 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Arteriohepatic dysplasia |
| RS121918352 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Arteriohepatic dysplasia |
| RS121918353 |
JAG1
|
Health Risk |
Likely pathogenic |
Deafness, congenital heart defects |
| RS121918354 |
PKP1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex due to plakophilin deficiency, Epidermolysis bullosa simplex due to plakophilin deficiency |
| RS121918355 |
LTBP2
|
Health Risk |
Pathogenic |
Glaucoma 3, primary congenital |
| RS121918356 |
LTBP2
|
Health Risk |
Pathogenic |
Glaucoma 3, primary congenital |
| RS121918357 |
SPG7
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia 7 |
| RS121918358 |
SPG7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 7, Proximal spinal muscular atrophy |
| RS121918359 |
SMAD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS121918360 |
PDE8B
|
Health Risk |
Pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS121918361 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS121918363 |
SRPX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Rolandic epilepsy, intellectual disability |
| RS121918365 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS121918366 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS121918367 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS121918368 |
CRBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 2 |
| RS121918370 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS121918371 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS121918374 |
PYCR1
|
Health Risk |
Pathogenic |
Autosomal recessive cutis laxa type 2B, Inborn genetic diseases |
| RS121918375 |
PYCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive cutis laxa type 2B, Cutis laxa |
| RS121918376 |
PYCR1
|
Health Risk |
Pathogenic |
Autosomal recessive cutis laxa type 2B, Cutis laxa |
| RS121918377 |
PYCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive cutis laxa type 2B, PYCR1-related de Barsy syndrome |
| RS121918378 |
PYCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
PYCR1-related de Barsy syndrome, Inborn genetic diseases |
| RS121918379 |
RDX
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS121918380 |
RDX
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS121918381 |
APOC3
|
Health Risk |
Pathogenic |
Apolipoprotein C-III, nonglycosylated |
| RS121918382 |
APOC3
|
Health Risk |
Pathogenic |
Apolipoprotein c-III deficiency, Apolipoprotein c-III deficiency |
| RS121918383 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia 1 |
| RS121918384 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia 1 |
| RS121918385 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia |
| RS121918386 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia, Familial hypercholesterolemia |
| RS121918387 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia 1 |
| RS121918388 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS121918389 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia |
| RS121918390 |
APOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypobetalipoproteinemia, Familial hypobetalipoproteinemia 1 |
| RS121918391 |
APOB
|
Health Risk |
Pathogenic |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS121918392 |
APOE
|
Health Risk |
Pathogenic |
HYPERLIPOPROTEINEMIA, TYPE III |
| RS121918393 |
APOE
|
Health Risk |
Likely pathogenic |
Familial type 3 hyperlipoproteinemia, Familial hypercholesterolemia |
| RS121918394 |
APOE
|
Health Risk |
Pathogenic |
Familial type 3 hyperlipoproteinemia, Hyperlipoproteinemia |
| RS121918395 |
APOE
|
Health Risk |
Pathogenic |
APOE2-DUNEDIN, HYPERLIPOPROTEINEMIA |
| RS121918396 |
APOE
|
Health Risk |
Likely pathogenic |
Familial type 3 hyperlipoproteinemia, HYPERLIPOPROTEINEMIA |
| RS121918397 |
APOE
|
Health Risk |
Pathogenic |
Familial type 3 hyperlipoproteinemia, Lipoprotein glomerulopathy |
| RS121918398 |
APOE
|
Health Risk |
Pathogenic |
APOE4 VARIANT, APOE4 VARIANT |
| RS121918399 |
APOE
|
Health Risk |
Pathogenic/Likely pathogenic |
Lipoprotein glomerulopathy, 7 conditions |
| RS121918400 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121918401 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS121918402 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS121918403 |
ENO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle beta-enolase deficiency, Glycogen storage disease due to muscle beta-enolase deficiency |
| RS121918405 |
FOLR1
|
Health Risk |
Pathogenic |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS121918406 |
FOLR1
|
Health Risk |
Pathogenic |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS121918407 |
GPD2
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS121918408 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS121918409 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS121918410 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS121918411 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS121918412 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS121918413 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS121918414 |
GLRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS121918415 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS121918416 |
GLRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 1, GLRA1-related disorder |
| RS121918417 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hyperekplexia 1 |
| RS121918418 |
GLRA1
|
Health Risk |
Pathogenic |
Hyperekplexia 1, Hereditary hyperekplexia |
| RS121918419 |
GYS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disease |
| RS121918420 |
GYS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |